In This Issue
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
Local and Other News
Be the first to know about new products, services, health care reform and more by subscribing to our newsletter. Visit our Profile and Preference Center to sign up today.
Reminder: Two preventive changes effective Dec. 1, 2017
November 17, 2017
Cholesterol screening (lipid disorders screening) – Effective Dec. 1, 2017
The United States Preventive Services Task Force (USPSTF) has revised its preventive recommendation for cholesterol screening and now includes cholesterol screening as a part of its new recommendation for statin use for the primary prevention of cardiovascular disease in adults, narrowing the age range and removing a number of restrictions. This change will go into effect for UnitedHealthcare standard plans on Dec. 1, 2017.
- Screening for Adults
- Screening members aged 40 to 75 ending on 76th birthday.
- Fewer diagnosis codes will be required with specific screening codes.
- USPSTF Rating: B.
Statin Use for the primary prevention of cardiovascular disease in adults – Effective Dec. 1, 2017 (May 15, 2017 in N.Y.)
The USPSTF recommends that adults without a history of cardiovascular disease use low- to moderate-dose statins for primary prevention of cardiovascular disease when certain risk factors are identified. As a result, some statins will become available at $0 cost-share for members who meet all of the following criteria and do not have a history of cardiovascular disease:
- Are between the ages of 40-75.
- Have one or more cardiovascular risk factors, such as dyslipidemia, diabetes, hypertension or smoking.
- Have a calculated 10-year risk of a cardiovascular event of 10 percent or greater.
This coverage will become available on Dec. 1, 2017, for most fully insured and self-funded groups that have standard health reform preventive coverage.
Not all statins will be covered at zero cost-share. Prior authorization will be required (with exception of lovastatin) to ensure that the member is using the medication for primary prevention of cardiovascular disease and has the noted risk factors. For members who do not go through prior authorization, statins will continue to be covered at their current tier.
For questions, please contact your UnitedHealthcare representative.
January 1, 2017 PDL Updates
The following updates will take effect for the OptumRx direct Prescription Drug Lists (PDLs) on January 1, 2017. Learn more
New Sales Automation Management Tool
Check out our new Sales Automation Management (SAM). Learn more
UnitedHealth Group News
Visit our newsroom for the latest about programs, reports and initiatives designed to help people live healthier lives.